compounding semaglutide enforcement news today Compound versions of GLP-1 drugs for weight loss halted by FDA Elite Start- 1-Month Compounded Semaglutide

p 50%) and very low certainty of evidence

J.JiZ.et al

It does not intervene with intra-abdominal fat

This means that the obesity pipeline has more than tripled itself - all in a single year!10/An interesting aspect of exponential obesity growth is the fact that while there are numerous programs in the GLP-1 agnostic space - 64 programs currently in development/approved, the other MOAs (mechanism of action) are uncrowded with 54 MOAs with only a single program $XBI12/One interesting program worth noticing - although still preclinical, is @WaveLifeSci INHBE silencing program for treating obesity - focusing not only on weight loss, but also on the restoration & maintenance of a healthy metabolic profile via RNA editing process

Expert analysis to help choose the right option